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Identity 
HGNC (Hugo): CTCF 
Location: 16q22.1 




See figure 1. 
Description 
76776 bp gene (Ensembl). 
Transcription 
Ubiquitously highly expressed gene (GeneCards), 12 





Figure 1. Schematic representation of CTCF location on chromosome 16, gene structure and transcripts. Chromosome 16 is 
represented with the characteristic banding pattern. The region surrounding the CTCF gene is enlarged. Genes are represented by 
arrows pointing in the direction of transcription. Transcripts are represented with exons as vertical bars and introns as lines. Distances 
are in kilo bases (NCBI Map Viewer). 
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Figure 2. Schematic representation of the CTCF protein. Protein sequences encoded by exons are boxed. 11 ring fingers are 
indicated by green boxes as also putative AT-hooks by blue boxes (Ensembl). Phosphorylated residues are in black (PhosphoSitePlus), 
those sensitive to rapamycin are indicated by R (Chen et al., 2009) and those phosphorylated by CKII by CKII (El-Kady et al., 2005; 
Klenova et al., 2001), sumoylated residues are in red (Kitchen et al., 2010; MacPherson et al., 2009), acetylated residue is indicated by 
Ac (Choudhary et al., 2009). The domain containing poly(ADPribosyl)ation sites (PAR) is boxed in red (Farrar et al., 2010). Residues 




CTCF was originally described as a c-myc activator 
(Klenova et al., 1993). It is a 727 aa protein with a MW 
of 82.8 kD, a charge of 8.5 and an iso electric point f 
6.95 (Ensembl). The central domain with 11 zinc 
fingers of the C2H2 type is highly conserved. 
Expression 
CTCF is an abundant and ubiquitously expressed 
protein, yet absent in primary spermatocytes (Loukinov 
et al., 2002). It is downregulated during differentiation 
of human myeloid leukemia cells (Delgado et al., 1999; 
Torrano et al., 2005). Post-traductional modifications 
include acetylation (Choudhary et al., 2009), 
sumoylation (Kitchen et al., 2010; MacPherson et al., 
2009), phosphorylation, in particular ser604-612 by 
CKII (El-Kady et al., 2005; Klenova et al., 2001), and 
poly(ADPribo)sylation (see figure 2). The latter 
modification is lost or decreased in proliferating cells 
and in BT (Docquier et al., 2009) (for sites and role see 
Farrar et al., 2010 and Yu et al., 2004). CTCF is a 
downstream target protein of growth factor-induced 
pathways and is regulated by EGF and insulin through 
activation of ERK and AKT signaling cascades (Gao et 
al., 2007). It was recently shown to be regulated by NF-
kB (Lu et al., 2010). 
Localisation 
CTCF is localized in the nucleoplasm of proliferating 
cells with exclusion from the nucleolus. It was detected 
at the centrosomes and midbody during mitosis (Zhang 
et al., 2004). It is associated with the nuclear matrix 
(Dunn et al., 2003; Yusufzai et al., 2004a) and the 
Lamina (Guelen et al., 2008; Ottaviani et al., 2009). 
Nucleolar translocation after growth arrest is 
accompanied by inhibition of nucleolar transcription 
(Torrano et al., 2006). Cytoplasmic expression was 
described in sporadic breast tumors (Rakha et al., 
2004). 
Function 
CTCF is an essential protein, since KO mice die before 
ED 9.5 (Heath et al., 2008) (reviewed in Filippova, 
2008 and Phillips et al., 2009). It interacts with up to 
39609 genomic sites (in ES cells) (Chen et al., 2008; 
Bao et al., 2007; Barski et al., 2007; Kim et al., 2007). 
The 11 Zn fingers would provide flexibility in DNA 
recognition (Filippova et al., 1996), the central 4 bind 
to a consensus DNA sequence (Filippova et al., 1998; 
Renda et al., 2007). Multiple interacting proteins were 
described including RNA polymerase II (Chernukhin et 
al., 2007), cohesin (Parelho et al., 2008; Rubio et al., 
2008; Wendt et al., 2008), Suz12 (Li et al., 2008), 
CHD8 (Ishihara et al., 2006), YY1 (Donohoe et al., 
2007), nucleophosmin (Yusufzai et al., 2004b), Kaiso 
(Defossez et al., 2005) and Sin3A (Lutz et al., 2000). 
Mediating DNA looping (Splinter et al., 2006) could be 
at the basis of most functions of CTCF. Long range 
interactions are cell type specific (Hou et al., 2010) and 
would depend on the chromosomal environment of the 
CTCF-binding sites, in particular its interaction with 
other factors (see concept of modular insulators in 
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Weth et al., 2010). One thoroughly studied factor is the 
thyroid receptor (Awad et al., 1999; Lutz et al., 2003). 
Its chromosomal environment could also explain the 
multiple (not necessarily exclusive) functions that were 
described for CTCF, including chromatin barrier 
(Cuddapah et al., 2008; Witcher et al., 2009), promoter 
insulation from enhancer (Bell et al., 1999) or silencer 
(Hou et al., 2008), transcriptional activation (Gombert 
et al., 2009) (for instance of the tumour suppressor 
genes INK4A/ARF (Rodriguez et al., 2010) and p53 
(Soto-Reyes et al., 2010)), repression (for instance 
hTERT (Renaud et al., 2005)), nucleosome positioning 
(Fu et al., 2008b), protection from DNA methylation 
(Mukhopadhyay et al., 2004; Schoenherr et al., 2003; 
Guastafierro et al., 2008), preservation of triplet-repeat 
stability (Cho et al., 2005; Filippova et al., 2001; Libby 
et al., 2008), imprinting (Fedoriw et al., 2004; 
Fitzpatrick et al., 2007), X chromosome inactivation 
(Chao et al., 2002), chromosome "kissing" (Ling et al., 
2006), transvection (Liu et al., 2008), death signaling 
(Docquier et al., 2005; Gomes et al., 2010; Li et al., 
2007), replication timing (Bergstrom et al., 2007), 
mitotic bookmarking (Burke et al., 2005) or MHC class 
II gene expression (Majumder et al., 2008). 
Homology 
49 orthologues were described including D. 
melanogaster (Smith et al., 2009) and C. elegans 
proteins (Moon et al., 2005), 3 paralogues: CTCFL or 
BORIS, originating from a gene duplication in reptiles 
(Hore et al., 2008; Loukinov et al., 2002), and possibly 
ZFP64 (Mack et al., 1997) and the Histone H4 
transcription factor HINF-P (van Wijnen et al., 199). 
Mutations 
Note 
SNP at AA 630 /K /E 90 /D /G 447 fR (NCBI). 
Germinal 
Non-coding mutations only. 
Somatic 
Mutations are rare and include point mutations of Zn-
fingers in breast (BT) (Aulmann et al., 2003), prostate 
(PT) and Wilms tumor (WT) (Filippova et al., 2002) 





LOH of CTCF was described in many cancers together 
with potential tumor suppressor genes (TSG), including 
E-Cad, since it is part of a larger deletion (Cancer 
Chromosomes; Sanger institute). In addition to WT 
(Yeh et al., 2002; Mummert et al., 2005), BT (Rakha et 
al., 2004), PT (Filippova et al., 1998), LOH was found 
in laryngeal squamous cell carcinoma (Grbesa et al., 
2008), however, there is no evidence that CTCF is the 
TSG at 16q22.1 (Rakha et al., 2005), except possibly in 
lobular carcinoma in situ of the breast (Green et al., 
2009). CTCF was also described to be overexpressed in 
BT (Docquier et al., 2005). An indirect role of CTCF in 
tumor progression is mainly suggested by mutation or 
aberrant methylation of its bindings sites (reviewed by 
Recillas-Targa et al., 2006). Interestingly, a causal link 
between LOH of CTCF and hypermethylation was 
proposed by Mummert et al. in 2005, although no real 
correlation was found by Yeh et al. in 2002. 
Methylation of CTCF sites was first described in the 
IGF2 imprinting control region in WT (Cui et al., 
2001). Aberrant methylation of this region was also 
found in PT (Fu et al., 2008a; Paradowska et al., 2009), 
HNSCC (De Castro Valente Esteves et al., 2006; 
Esteves et al., 2005), colorectal cancer (Nakagawa et 
al., 2001), osteosarcoma (Ulaner et al., 2003), ovarian 
carcinoma (Dammann et al., 2010) and laryngeal 
squamous cell carcinoma (Grbesa et al., 2008). 
Hypomethylation was described in bladder cancer 
(Takai et al., 2001). Microdeletions were described in 
Beckwith-Wiedemann syndrome and WT (Prawitt et 
al., 2005; Sparago et al., 2007). Other methylated 
CTCF targets were found in the genes AWT1 or WT1-
AS in WT (Hancock et al., 2007), Bcl6 in B cell 
lymphomas (Lai et al., 2010), p53, pRb (De La Rosa-
Velazquez et al., 2007), ARF (Tam et al., 2003; 
Rodriguez et al., 2010), INK4B, BRCA1 (Butcher et 
al., 2004; Butcher et al., 2007; Xu et al., 2010) and 
Rasgrf1 (Yoon et al., 2005).  
We describe below the rare cases of point mutations 
affecting the CTCF protein. 
Invasive ductal breast carcinoma, grade 
2 
Note 
G2 grade tumor, no protein detected (Aulmann et al., 
2003). 
Cytogenetics 
14 bp insertion at AA D91, see figure 2. 
Invasive ductal breast carcinoma, grade 
3 
Note 
G3 grade tumor (Aulmann et al., 2003). 
Cytogenetics 
LOH and Q72H, figure 2. 
Breast cancer 
Note 
Zinc finger mutation (Filippova et al., 2002). 
Cytogenetics 
LOH and K343E, figure 2. 
Prostate cancer 
Note 
Zinc finger mutation (Filippova et al., 2002). 
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Cytogenetics 
LOH and H344E, figure 2. 
Wilms tumor 
Note 
Zinc finger mutation (Filippova et al., 2002). 
Cytogenetics 
LOH and R339W or R448Q, figure 2. 
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